SCHEMBL29533014

SCHEMBL29533014

O=C1CCC(N2C(=O)Cc3ccc(Br)c4cccc2c34)C(=O)N1

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 18/20 0.65
DDB1 Q16531 15/20 0.65
IKZF3 Q9UKT9 2/20 0.45
ALDH1A1 P00352 1/20 0.45
CHRM2 P08172 1/20 0.45
OPRM1 P35372 1/20 0.45
CYP1A2 P05177 1/20 0.45
TSHR P16473 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
BCL2L11 O43521 1/20 0.45
BCL2 P10415 1/20 0.45
MCL1 Q07820 1/20 0.45
TNF P01375 1/20 0.41
IL1B P01584 1/20 0.41
TBXA2R P21731 1/20 0.41
IKZF1 Q13422 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24317855 1.00 CRBN (0.65) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL24317309 0.82 CRBN (0.76) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL29532472 0.82 CRBN (0.48) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL29532161 0.82 BCL2L11 (0.59) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL24317922 0.82 CRBN (0.48) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL24330298 0.82 CRBN (0.50) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL24315710 0.82 BCL2L11 (0.59) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL24317401 0.80 CRBN (0.46) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL24329219 0.80 BCL2L11 (0.49) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL29582897 0.80 BCL2L11 (0.49) CRBNDDB1IKZF3ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116723839-A Tricyclic heterobifunctional compounds for degrading target proteins C4医药公司 2023-09-08 CN disclosed
EP-4228625-A1 TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS C4 Therapeutics, Inc. (US) 2023-08-23 EP disclosed
EP-4228624-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 Therapeutics, Inc. (US) 2023-08-23 EP disclosed
WO-2022081927-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed
WO-2022081928-A1 TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed